Neuroendocrine Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-07-01
Clinical Trial Update: Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers [Phase 2]
Phase 2 clinical trial update evaluating carfilzomib for advanced neuroendocrine cancers has completed with results posted.